Arca
Skip to content
Tools
Tools

Warning Letter to Dubak Electrical Group

Medical Devices. See Dubak Electrical Group's company page or this site's inspections.

On Jul 20, 2023, FDA's CDRH sent Dubak Electrical Group a warning letter.

  • Letter date: Jul 20, 2023
  • Issued by: CDRH
  • Closeout: โ€”

The Letter

As posted on FDA.gov โ†—; cited 21 CFR sections link to their page.

Dear Nebojsa โ€œNickโ€ Dubak:

The Food and Drug Administration has completed an evaluation of your firmโ€™s corrective actions in response to our Warning Letter (CMS # 613511, dated March 4, 2021). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed in the future.

Sincerely yours, /S/ Courtney H. Lias, Ph.D. Office Director OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

The Firm's Other Letters

Same company or the same FDA site, newest first

Record

Recipient
Nebojsa โ€œNickโ€ Dubak
FDA site ID (FEI)
3014204295
Cited
โ€”

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.